India  

Covishield side effects disclosed in packaging: SII

IndiaTimes Thursday, 9 May 2024
Serum Institute of India stopped Covishield production due to reduced demand post high vaccination rates. They disclosed rare side effects like Thrombosis with thrombocytopenia syndrome since 2021, emphasizing transparency commitment. AstraZeneca acknowledged this rare side effect.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Side Effects May Include (a prescription medicine commercial parody) [Video]

Side Effects May Include (a prescription medicine commercial parody)

This hilarious video takes a satirical look at the often absurd and endless list of side effects mentioned in pharmaceutical commercials. Watch as everyday activities and bizarre occurrences are..

Credit: Rumble     Duration: 02:40Published